A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Clinical trial NCT02561039 · COMPLETED

Trial details

NCT number: NCT02561039
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pain; Bone Neoplasms; Neoplasm Metastasis

Start date: 2006-12-01
Primary completion: 2008-03-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.